Changing The Way diseases are treated
Cancers / neural / Autoimmune diseases
We develop novel therapies for complicated diseases
through modulating multiple immune responses and signal pathways
MINC(Multi-target Immunotherapy NanoComplex) Technology
MINC(Multi-target Immunotherapy NanoComplex) Technology
-- A Multi-target-Immunotherapy Platform
SUNTEC is leveraging its proprietary MINC technology platform to develop Multi-target Immunotherapies with extraordinary . MINC drugs are unique in that they 1) can penetrate the BBB 2) modulate multiple immune/signaling pathways of disease for high efficacy and response rates, and 3) reduce drug toxicity.
Our strategy
MINC technology is a “new drug discovery platform” for multi-target immuno-biopharmaceuticals. Suntec focus in developing new biopharmaceuticals for cancer, central nervous system (CNS) and autoimmune (AI) diseases. MINC can also create new drugs to treat cardiovascular diseases (CVD), infectious diseases, gene therapies and vaccines.